tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Immunovia Secures SEK 100 Million for PancreaSure Launch
Company AnnouncementsImmunovia Secures SEK 100 Million for PancreaSure Launch
18h ago
Immunovia AB Concludes Trading in Rights Issue Subscription
PremiumCompany Announcements
Immunovia AB Concludes Trading in Rights Issue Subscription
8d ago
Immunovia’s North Carolina Lab Achieves CAP Accreditation
PremiumCompany Announcements
Immunovia’s North Carolina Lab Achieves CAP Accreditation
11d ago
Immunovia Showcases Pancreatic Cancer Surveillance Advances
PremiumCompany Announcements
Immunovia Showcases Pancreatic Cancer Surveillance Advances
14d ago
Immunovia AB Announces SEK 100 Million Rights Issue to Bolster Financial Position
PremiumCompany Announcements
Immunovia AB Announces SEK 100 Million Rights Issue to Bolster Financial Position
21d ago
Immunovia AB Adopts Key Resolutions to Strengthen Financial Position
PremiumCompany AnnouncementsImmunovia AB Adopts Key Resolutions to Strengthen Financial Position
25d ago
Immunovia AB Finalizes Terms for SEK 100 Million Rights Issue
Premium
Company Announcements
Immunovia AB Finalizes Terms for SEK 100 Million Rights Issue
29d ago
Immunovia’s PancreaSure Test Shows Promising Results in Detecting Pancreatic Cancer
Premium
Company Announcements
Immunovia’s PancreaSure Test Shows Promising Results in Detecting Pancreatic Cancer
30d ago
Immunovia Secures Cost-Effective Supply Chain for PancreaSure Test
PremiumCompany Announcements
Immunovia Secures Cost-Effective Supply Chain for PancreaSure Test
1M ago
Onconetix’s Proteomedix licenses manufacturing IP to Immunovia
PremiumThe Fly
Onconetix’s Proteomedix licenses manufacturing IP to Immunovia
1M ago
ONCO
Immunovia’s PancreaSure Test Adopted by Inova Schar Cancer for Enhanced Pancreatic Surveillance
PremiumCompany Announcements
Immunovia’s PancreaSure Test Adopted by Inova Schar Cancer for Enhanced Pancreatic Surveillance
1M ago
CMS Sets Preliminary Payment for Immunovia’s PancreaSure Test
PremiumCompany Announcements
CMS Sets Preliminary Payment for Immunovia’s PancreaSure Test
1M ago
Immunovia Secures Full Guarantee for SEK 100 Million Rights Issue
PremiumCompany AnnouncementsImmunovia Secures Full Guarantee for SEK 100 Million Rights Issue
2M ago
Immunovia Launches PancreaSure Test for Early Pancreatic Cancer Detection
Premium
Company Announcements
Immunovia Launches PancreaSure Test for Early Pancreatic Cancer Detection
2M ago
Immunovia AB Reports Q2 2025 Earnings and Prepares for PancreaSure Launch
Premium
Company Announcements
Immunovia AB Reports Q2 2025 Earnings and Prepares for PancreaSure Launch
2M ago
Immunovia Advances Pancreatic Cancer Diagnostics Amid Financial Challenges
PremiumCompany Announcements
Immunovia Advances Pancreatic Cancer Diagnostics Amid Financial Challenges
2M ago
Immunovia AB Announces EGM for Strategic Amendments
PremiumCompany Announcements
Immunovia AB Announces EGM for Strategic Amendments
2M ago
Immunovia AB Announces SEK 100 Million Rights Issue for PancreaSure Launch
PremiumCompany Announcements
Immunovia AB Announces SEK 100 Million Rights Issue for PancreaSure Launch
2M ago
Immunovia to Announce Q2 Results and Launch PancreaSure Test
PremiumCompany Announcements
Immunovia to Announce Q2 Results and Launch PancreaSure Test
2M ago
Immunovia to Launch PancreaSure Test in US, Outlines Commercial Strategy
PremiumCompany AnnouncementsImmunovia to Launch PancreaSure Test in US, Outlines Commercial Strategy
2M ago
Immunovia’s PancreaSure Test Gains Prestigious Recognition
Premium
Company Announcements
Immunovia’s PancreaSure Test Gains Prestigious Recognition
3M ago
Immunovia Strengthens Leadership with Key Appointment
Premium
Company Announcements
Immunovia Strengthens Leadership with Key Appointment
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >